Total Payments
$79,374
2024 Payments
$13,582
Companies
29
Transactions
313
Medicare Patients
2,345
Medicare Billing
$307,122
Payment Breakdown by Category
Other$72,305 (91.1%)
Food & Beverage$6,305 (7.9%)
Consulting$750.00 (0.9%)
Education$13.46 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $67,305 | 47 | 84.8% |
| Food and Beverage | $6,305 | 261 | 7.9% |
| Compensation for serving as faculty or as a speaker for a non-accredited and noncertified continuing education program | $5,000 | 2 | 6.3% |
| Consulting Fee | $750.00 | 1 | 0.9% |
| Education | $13.46 | 2 | 0.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Allergan, Inc. | $36,644 | 71 | $0 (2020) |
| ABBVIE INC. | $19,010 | 103 | $0 (2024) |
| IRONWOOD PHARMACEUTICALS, INC | $10,354 | 35 | $0 (2024) |
| Phathom Pharmaceuticals, Inc. | $6,059 | 8 | $0 (2024) |
| Shionogi Inc | $6,000 | 8 | $0 (2019) |
| PFIZER INC. | $259.54 | 13 | $0 (2024) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $158.28 | 11 | $0 (2024) |
| Takeda Pharmaceuticals U.S.A., Inc. | $104.57 | 11 | $0 (2022) |
| Celgene Corporation | $99.11 | 7 | $0 (2023) |
| Janssen Biotech, Inc. | $84.31 | 6 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $13,582 | 33 | Phathom Pharmaceuticals, Inc. ($6,059) |
| 2023 | $8,050 | 27 | AbbVie Inc. ($5,515) |
| 2022 | $6,650 | 27 | ABBVIE INC. ($4,189) |
| 2021 | $6,038 | 29 | AbbVie Inc. ($5,816) |
| 2020 | $7,679 | 28 | Allergan, Inc. ($7,254) |
| 2019 | $18,519 | 57 | Allergan Inc. ($11,707) |
| 2018 | $13,378 | 69 | Allergan Inc. ($12,635) |
| 2017 | $5,477 | 43 | Allergan Inc. ($5,048) |
All Payment Transactions
313 individual payment records from CMS Open Payments — Page 1 of 13
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/13/2024 | ABBVIE INC. | LINZESS (Drug), CREON | Food and Beverage | In-kind items and services | $7.78 | General |
| Category: GASTROENTEROLOGY | ||||||
| 12/11/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $18.11 | General |
| Category: IMMUNOLOGY | ||||||
| 12/09/2024 | IRONWOOD PHARMACEUTICALS, INC | Linzess (Drug) | Food and Beverage | Cash or cash equivalent | $10.78 | General |
| Category: GI | ||||||
| 10/23/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $11.47 | General |
| Category: IMMUNOLOGY | ||||||
| 10/02/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,075.00 | General |
| Category: GASTROENTEROLOGY | ||||||
| 09/16/2024 | ABBVIE INC. | SKYRIZI (Biological), RINVOQ | Food and Beverage | In-kind items and services | $14.91 | General |
| Category: IMMUNOLOGY | ||||||
| 09/16/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $1.67 | General |
| Category: IMMUNOLOGY | ||||||
| 08/26/2024 | IRONWOOD PHARMACEUTICALS, INC | Linzess (Drug) | Food and Beverage | Cash or cash equivalent | $7.45 | General |
| Category: GI | ||||||
| 08/26/2024 | IRONWOOD PHARMACEUTICALS, INC | Linzess (Drug) | Food and Beverage | Cash or cash equivalent | $6.09 | General |
| Category: GI | ||||||
| 08/07/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,720.00 | General |
| Category: GASTROENTEROLOGY | ||||||
| 08/02/2024 | ABBVIE INC. | VIBERZI (Drug), CREON | Food and Beverage | In-kind items and services | $13.30 | General |
| Category: GASTROENTEROLOGY | ||||||
| 07/30/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $121.47 | General |
| Category: GASTROENTEROLOGY | ||||||
| 07/16/2024 | PFIZER INC. | VELSIPITY (Drug) | Food and Beverage | In-kind items and services | $13.43 | General |
| Category: INFLAMMATION;PAIN | ||||||
| 07/01/2024 | ABBVIE INC. | LINZESS (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,375.00 | General |
| Category: GASTROENTEROLOGY | ||||||
| 07/01/2024 | IRONWOOD PHARMACEUTICALS, INC | Linzess (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,375.00 | General |
| Category: GI | ||||||
| 07/01/2024 | IRONWOOD PHARMACEUTICALS, INC | Linzess (Drug) | Food and Beverage | Cash or cash equivalent | $13.45 | General |
| Category: GI | ||||||
| 05/21/2024 | IRONWOOD PHARMACEUTICALS, INC | Linzess (Drug) | Food and Beverage | Cash or cash equivalent | $15.89 | General |
| Category: GI | ||||||
| 05/20/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $9.23 | General |
| Category: GASTROENTEROLOGY | ||||||
| 05/16/2024 | ABBVIE INC. | LINZESS (Drug) | Food and Beverage | In-kind items and services | $128.68 | General |
| Category: GASTROENTEROLOGY | ||||||
| 05/08/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $13.09 | General |
| Category: Gastroenterology | ||||||
| 04/26/2024 | ABBVIE INC. | CREON (Drug) | Food and Beverage | In-kind items and services | $15.53 | General |
| Category: ENDOCRINOLOGY | ||||||
| 04/16/2024 | IRONWOOD PHARMACEUTICALS, INC | Linzess (Drug) | Food and Beverage | Cash or cash equivalent | $8.65 | General |
| Category: GI | ||||||
| 04/08/2024 | IRONWOOD PHARMACEUTICALS, INC | Linzess (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,375.00 | General |
| Category: GI | ||||||
| 04/08/2024 | IRONWOOD PHARMACEUTICALS, INC | Linzess (Drug) | Food and Beverage | Cash or cash equivalent | $30.57 | General |
| Category: GI | ||||||
| 04/08/2024 | ABBVIE INC. | MAVYRET (Drug) | Food and Beverage | In-kind items and services | $13.50 | General |
| Category: VIROLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 14 | 578 | 1,073 | $537,735 | $77,986 |
| 2022 | 13 | 622 | 1,276 | $519,049 | $88,265 |
| 2021 | 16 | 680 | 1,271 | $533,523 | $88,550 |
| 2020 | 9 | 465 | 665 | $361,018 | $52,322 |
Total Patients
2,345
Total Services
4,285
Medicare Billing
$307,122
Procedure Codes
52
All Medicare Procedures & Services
52 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 127 | 193 | $45,648 | $14,271 | 31.3% |
| 99439 | Chronic care management services for two or more chronic conditions, additional 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 18 | 269 | $28,245 | $11,108 | 39.3% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2023 | 86 | 89 | $164,849 | $9,989 | 6.1% |
| 99490 | Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 18 | 155 | $23,250 | $8,193 | 35.2% |
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2023 | 37 | 37 | $84,702 | $7,622 | 9.0% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 76 | 76 | $28,236 | $6,450 | 22.8% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2023 | 72 | 75 | $99,000 | $6,404 | 6.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 32 | 35 | $12,682 | $3,836 | 30.2% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 28 | 51 | $16,269 | $3,531 | 21.7% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 21 | 21 | $14,259 | $2,390 | 16.8% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 17 | 17 | $9,940 | $1,917 | 19.3% |
| 99221 | Initial hospital care with straightforward or low level of medical decision making, per day, if using time, at least 40 minutes | Facility | 2023 | 13 | 13 | $5,759 | $944.19 | 16.4% |
| 99441 | Telephone medical discussion with physician, 5-10 minutes | Office | 2023 | 22 | 27 | $2,880 | $783.57 | 27.2% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 11 | 15 | $2,016 | $547.33 | 27.1% |
| 99439 | Chronic care management services for two or more chronic conditions, additional 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2022 | 21 | 335 | $35,175 | $14,101 | 40.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 129 | 192 | $41,588 | $13,801 | 33.2% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 72 | 171 | $54,549 | $10,549 | 19.3% |
| 99490 | Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2022 | 21 | 179 | $26,850 | $9,845 | 36.7% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2022 | 78 | 80 | $128,194 | $8,536 | 6.7% |
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2022 | 39 | 40 | $80,218 | $8,381 | 10.4% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2022 | 71 | 74 | $88,175 | $6,157 | 7.0% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 72 | 72 | $22,296 | $6,157 | 27.6% |
| 99221 | Initial hospital inpatient care per day, typically 30 minutes | Facility | 2022 | 42 | 45 | $19,935 | $3,959 | 19.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 34 | 38 | $12,309 | $3,705 | 30.1% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 13 | 13 | $6,678 | $1,883 | 28.2% |
About Dr. Andrew Boxer, M.D
Dr. Andrew Boxer, M.D is a Gastroenterology healthcare provider based in Verona, New Jersey. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/06/2008. The National Provider Identifier (NPI) number assigned to this provider is 1225294499.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Andrew Boxer, M.D has received a total of $79,374 in payments from pharmaceutical and medical device companies, with $13,582 received in 2024. These payments were reported across 313 transactions from 29 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($67,305).
As a Medicare-enrolled provider, Boxer has provided services to 2,345 Medicare beneficiaries, totaling 4,285 services with total Medicare billing of $307,122. Data is available for 4 years (2020–2023), covering 52 distinct procedure/service records.
Ad
Practice Information
- Specialty Gastroenterology
- Location Verona, NJ
- Active Since 08/06/2008
- Last Updated 08/09/2023
- Taxonomy Code 207RG0100X
- Entity Type Individual
- NPI Number 1225294499
Products in Payments
- LINZESS (Drug) $51,944
- Linzess (Drug) $10,094
- VOQUEZNA (Drug) $6,059
- Mulpleta (Drug) $6,000
- VIBERZI (Drug) $2,759
- Humira (Biological) $334.17
- Creon (Drug) $261.42
- XELJANZ (Drug) $246.11
- CREON (Drug) $238.87
- RINVOQ (Biological) $121.89
- HUMIRA (Biological) $110.49
- XIFAXAN (Drug) $109.07
- ZEPOSIA (Drug) $99.11
- Entyvio (Biological) $65.27
- Dexilant (Drug) $65.20
- STELARA (Biological) $57.76
- DIFICID (Drug) $57.49
- MAVYRET (Drug) $54.75
- ZIO Patch (Device) $42.04
- Mavyret (Drug) $39.99
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Gastroenterology Doctors in Verona
Dr. Oleg Shulik, M.d, M.D
Gastroenterology — Payments: $2,446
Gastroenterology $2,446
Sameet Shah, D.o, D.O
Gastroenterology — Payments: $598.39
Gastroenterology $598.39
Dr. Joel Lans, M.d, M.D
Gastroenterology — Payments: $340.77
Gastroenterology $340.77
Dr. Daniel Manzi, M.d, M.D
Gastroenterology — Payments: $22.86
Gastroenterology $22.86